Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$328K Sell
1,483
-780
-34% -$191K ﹤0.01% 1191
2025
Q4
$578K Sell
2,263
-410
-15% -$103K 0.01% 858
2025
Q3
$661K Sell
2,673
-696
-21% -$167K 0.01% 802
2025
Q2
$809K Sell
3,369
-3,076
-48% -$716K 0.01% 665
2025
Q1
$1.46M Sell
6,445
-216
-3% -$47.5K 0.02% 434
2024
Q4
$1.37M Sell
6,661
-646
-9% -$142K 0.02% 460
2024
Q3
$1.72M Buy
7,307
+451
+7% +$105K 0.03% 395
2024
Q2
$1.5M Buy
6,856
+5,391
+368% +$1.17M 0.03% 387
2024
Q1
$329K Buy
1,465
+8
+0.5% +$1.8K 0.01% 505
2023
Q4
$320K Buy
+1,457
New +$308K 0.01% 479

Other funds holding STE

Choreo LLC's STE Position: Q1 2026 in Review

Choreo LLC reduced its Steris (STE) stake by 34% in Q1 2026, selling an estimated $191K and leaving 1,483 shares worth $328K. The position accounts for ﹤0.01% of the portfolio, ranked #1191.

Choreo LLC first reported a position in STE in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.72M in Q3 2024. 838 funds tracked by Wall St. Rank hold STE as of Q1 2026.

  • Choreo LLC held 1,483 shares of Steris worth $328K as of Q1 2026.
  • Choreo LLC sold 780 Steris shares in Q1 2026, an estimated $191K.
  • Steris made up ﹤0.01% of Choreo LLC's portfolio in Q1 2026, its #1191 holding.
  • Choreo LLC first reported a position in Steris in Q4 2023 and has held it in 10 quarters since.
  • Choreo LLC's Steris position peaked at $1.72M in Q3 2024.
  • 838 funds tracked by Wall St. Rank held Steris as of Q1 2026.

Based on Choreo LLC's 13F filing for Q1 2026, filed 13 May 2026.